Alterity Therapeutics Limited
PRNAF
$0.0088
-$0.0013-12.87%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.75% | 42.19% | -0.21% | -95.64% | 0.47% |
| Total Depreciation and Amortization | -2.47% | 0.00% | 0.41% | 0.41% | -0.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.74% | 150.75% | 0.20% | -2.91% | -0.48% |
| Change in Net Operating Assets | 2.75% | -149.50% | 0.21% | 156.80% | -0.47% |
| Cash from Operations | 2.75% | -4.79% | -0.21% | -82.09% | 0.48% |
| Capital Expenditure | -- | -- | -- | 100.00% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -253.60% | 0.00% | 181.02% | 0.00% |
| Issuance of Common Stock | 0.00% | -95.46% | 0.00% | 541.24% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 95.11% | 0.00% | -148.52% | 0.00% |
| Cash from Financing | -2.70% | -96.29% | 0.20% | 684.43% | -0.47% |
| Foreign Exchange rate Adjustments | 2.19% | -115.78% | 0.23% | 8,760.00% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.74% | -2,687.61% | 0.19% | 109.30% | 0.48% |
